German University Recruiting for Cannabis Clinical Trials
German cannabis clinical trials are expanding as a university seeks study participants. This development signals growing scientific legitimacy for cannabis research in Europe. Participation in these trials could advance evidence-based therapeutic…
US to reclassify medical marijuana | Dr. Tara Narula – Facebook
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyRegulationMedical CannabisSchedule…
Trump Administration Moves to Reclassify Marijuana as Schedule III Drug | National News
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyFederal RegulationClinical…
Colorado cannabis leaders enthusiastic about marijuana rescheduling
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyClinical ResearchFederal…
DOJ Reschedules Medical Marijuana, Excludes NY Recreational Shops
The DOJ medical marijuana rescheduling marks a pivotal federal policy shift. This change affects medical cannabis regulation and patient access nationwide. However, NY's recreational shops remain excluded from this update.
Trump Administration Moves to Reschedule Medical Marijuana | WUNC News
The 2026 medical marijuana rescheduling policy marks a significant shift in federal cannabis regulation. This change could enhance clinical research opportunities and patient access. It represents a pivotal moment for medical cannabis policy and practice.
State-licensed medical marijuana reclassified to Schedule III drug. What it means for Kentucky – AOL
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisClinical…
Trump moves to reschedule marijuana – POLITICO
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyFederal RegulationMedical…
Here’s how rescheduling medical cannabis might affect consumers | New Hampshire Public Radio
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisFederal…
Trump Moves to Reclassify Cannabis: What Does That Mean? – Deseret News
The Trump cannabis policy update signals a significant shift in federal regulations. This reclassification could expand medical cannabis research opportunities. Understanding these changes is crucial for clinicians and patients alike.
